Is Early Cardioversion for Atrial Fibrillation Safe in Patients with Spontaneous Echocardiographic Contrast?PATEL, S. V; FLAKER, Greg.Clinical cardiology (Mahwah, NJ). 2008, Vol 31, Num 4, pp 148-152, issn 0160-9289, 5 p.Article

Chest pain after cocaine inhalation : Air in the mediastinum!GOEL, Punit; FLAKER, Greg C.Cardiovascular reviews & reports. 2001, Vol 22, Num 3, pp 146-148, issn 0197-3118Article

C-reactive protein in coronary artery diseaseJAYAM, Vinod; FLAKER, Greg.Cardiovascular reviews & reports. 2000, Vol 21, Num 10, pp 554-557, issn 0197-3118Article

Acute myocardial injury following extracorporeal shock wave lithotripsySINGH, Karandeep; JAYAM, Vinod; FLAKER, Greg C et al.Cardiovascular reviews & reports. 2001, Vol 22, Num 7, pp 406-410, issn 0197-3118, 3 p.Article

Cardiac safety of conducted electrical devices in pigs and their effect on pacemaker functionKHAJA, Azamuddin; GOVINDARAJAN, Gurushankar; MCDANIEL, Wayne et al.The American journal of emergency medicine. 2011, Vol 29, Num 9, pp 1089-1096, issn 0735-6757, 8 p.Article

Atrial flutter in a college football player: Return to play or not?WEN, Dennis Y; FLAKER, Greg; SHARP, Rex L et al.Physician and sportsmedicine. 2003, Vol 31, Num 10, pp 21-24, issn 0091-3847, 4 p., 35 [5 p.]Article

Apixaban in Patients with Atrial FibrillationCONNOLLY, Stuart J; EIKELBOOM, John; TALAJIC, Mario et al.The New England journal of medicine. 2011, Vol 364, Num 9, pp 806-817, issn 0028-4793, 12 p.Article

Ventricular pacing or dual-chamber pacing for sinus-node dysfunctionLAMAS, Gervasio A; LEE, Kerry L; HELLKAMP, Anne S et al.The New England journal of medicine. 2002, Vol 346, Num 24, pp 1854-1862, issn 0028-4793Article

Sudden Cardiac Death in Patients With Stable Coronary Artery Disease and Preserved Left Ventricular Systolic FunctionHSIA, Judith; JABLONSKI, Kathleen A; SOLOMON, Scott et al.The American journal of cardiology. 2008, Vol 101, Num 4, pp 457-461, issn 0002-9149, 5 p.Article

Death in patients with permanent pacemakers for sick sinus syndromeFLAKER, Greg; GREENSPON, Arnold; TARDIFF, Barbara et al.The American heart journal. 2003, Vol 146, Num 5, pp 887-893, issn 0002-8703, 7 p.Article

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation)FLAKER, Greg; LOPES, Renato D; VINEREANU, Dragos et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 11, pp 1082-1087, issn 0735-1097, 6 p.Article

The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patientsLAMAS, Gervasio A; LEE, Kerry; BERNSTEIN, Robert et al.The American heart journal. 2000, Vol 140, Num 4, pp 541-551, issn 0002-8703Article

Apixaban versus Warfarin in Patients with Atrial FibrillationGRANGER, Christopher B; ALEXANDER, John H; CECILIA BAHIT, M et al.The New England journal of medicine. 2011, Vol 365, Num 11, pp 981-992, issn 0028-4793, 12 p.Article

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing CardioversionNAGARAKANTI, Rangadham; EZEKOWITZ, Michael D; REILLY, Paul A et al.Circulation (New York, N.Y.). 2011, Vol 123, Num 2, pp 131-136, issn 0009-7322, 6 p.Article

Dronedarone in High-Risk Permanent Atrial FibrillationCONNOLLY, Stuart J; CAMM, A. John; BUDAJ, Andrzej et al.The New England journal of medicine. 2011, Vol 365, Num 24, pp 2268-2276, issn 0028-4793, 9 p.Article

Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatmentEIKELBOOM, John W; O'DONNELL, Martin; POGUE, Janice et al.The American heart journal. 2010, Vol 159, Num 3, pp 348-353, issn 0002-8703, 6 p.Article

Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk : The Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE-W)HEALEY, Jeff S; HART, Robert G; POGUE, Janice et al.Stroke (1970). 2008, Vol 39, Num 5, pp 1482-1486, issn 0039-2499, 5 p.Article

Window to the heart: The value of a native and paced QRS duration. Current perspective and reviewSHUKLA, Himanshu H; JAMES, Erskine A; SCHUTZ, John A et al.Journal of interventional cardiac electrophysiology (Print). 2003, Vol 9, Num 3, pp 333-342, issn 1383-875X, 10 p.Article

Asymptomatic atrial fibrillation : Demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) studyFLAKER, Greg C; BELEW, Kathy; BECKMAN, Karen et al.The American heart journal. 2005, Vol 149, Num 4, pp 657-663, issn 0002-8703, 7 p.Article

Impact of diabetes on mortality in patients with myocardial infarction and left Ventricular dysfunctionMURCIA, Alvaro M; HENNEHENS, Charles H; LAMAS, Gervasio A et al.Archives of internal medicine (1960). 2004, Vol 164, Num 20, pp 2273-2279, issn 0003-9926, 7 p.Article

Cognitive Function and Anticoagulation Control in Patients With Atrial FibrillationFLAKER, Greg C; POGUE, Janice; YUSUF, Salim et al.Circulation. Cardiovascular quality and outcomes (Print). 2010, Vol 3, Num 3, pp 277-283, issn 1941-7713, 7 p.Article

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation : An exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trialsFLAKER, Greg C; GRUBER, Michael; CONNOLLY, Stuart J et al.The American heart journal. 2006, Vol 152, Num 5, pp 967-973, issn 0002-8703, 7 p.Article

Predictors of late development of Heart failure in stable survivors of myocardial infarction: The CAREstudyLEWIS, Eldrin F; MOYE, Lemuel A; ROULEAU, Jean L et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 8, pp 1446-1453, issn 0735-1097, 8 p.Article

Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin κ Antagonist Treatment (AVERROES) TrialFLAKER, Greg C; EIKELBOOM, John W; SHESTAKOVSKA, Olga et al.Stroke (1970). 2012, Vol 43, Num 12, pp 3291-3297, issn 0039-2499, 7 p.Article

Predictors of stroke in patients paced for sick sinus syndrome. CommentaryGREENSPON, Arnold J; HART, Robert G; KERR, Charles R et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 9, pp 1617-1624, issn 0735-1097, 8 p.Article